Brain Metastases Prognostic Index

Estimate prognosis in patients with brain metastases using the graded prognostic assessment

Questions

1.Tumor Type?
2.Karnofsky Performance Score (KPS)?
3.Extracranial Metastases?
4.Number of Brain Metastases?
5.Age?
6.If Breast Cancer, cancer subtype?

About

Due to significant heterogeneity in survival after brain metastases that depends, in part, on the primary tumor, a diagnosis-specific prognostic index was developed.

The diagnosis-specific graded prognostic assessment (DS-GPA) is based on an analysis of 3940 patients with newly diagnosed brain metastases.

Unique prognostic models were developed for patients with non-small cell lung cancer, small cell lung cancer, melanoma, renal cell carcinoma, breast cancer, and gastrointestinal cancer.

References

Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M.

Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases.

Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2012 February 1, 30 (4): 419-25

The Brain Metastases Prognostic Index calculator is created by QxMD.

Created by on 03/09/2017

By using this site you acknowledge that you have read, understand, and agree to be bound by our terms of use and privacy policy. All content and tools are for educational use only, are not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.

1. Tumor Type?

More Information

This tool can be used for non-small cell lung cancer, small cell lung cancer, melanoma, renal cell carcinoma, breast cancer, and gastrointestinal cancer.

0/6 completed